Skip to main content
. Author manuscript; available in PMC: 2007 Jan 22.
Published in final edited form as: Eur J Neurosci. 2006 May;23(10):2635–2647. doi: 10.1111/j.1460-9568.2006.04805.x

Fig. 8.

Fig. 8

(A) The level of Thy-1 in N2a/22L cells treated with various Mabs. The level of Thy-1 in N2a/22L cells was more than twice than in N2a cells. Mabs 7D9 and 8F9, which showed no significant therapeutic effect, had no impact on the Thy-1 level. Incubation of N2a/22L cells with therapeutically effective Mabs caused a significant reduction in Thy-1 level. One-way ANOVA (P < 0.001) was followed by a Dunnett post hoc test; *P < 0.05, **P < 0.01. (B) Thy-1 in cell lysates following treatment with specific Mabs.